Rockefeller Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$32K Buy
455
+205
+82% +$13.8K ﹤0.01% 447
2017
Q3
$17K Buy
+250
New +$15.8K ﹤0.01% 484
2014
Q1
Sell
-93
Closed -$6K 508
2013
Q4
$6K Buy
+93
New +$5.05K ﹤0.01% 467

Other funds holding AZN

Rockefeller Financial Services's AZN Position: Q4 2017 in Review

Rockefeller Financial Services increased its AstraZeneca (AZN) stake by 82% in Q4 2017, buying an estimated $13.8K and bringing the position to 455 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

Rockefeller Financial Services first reported a position in AZN in Q4 2013 and has held it in 3 quarters since. 502 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • Rockefeller Financial Services held 455 shares of AstraZeneca worth $32K as of Q4 2017.
  • Rockefeller Financial Services bought 205 AstraZeneca shares in Q4 2017, an estimated $13.8K.
  • AstraZeneca made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #447 holding.
  • Rockefeller Financial Services first reported a position in AstraZeneca in Q4 2013 and has held it in 3 quarters since.
  • 502 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.